CYP 3.92% 24.5¢ cynata therapeutics limited

2020 - A Year Full Of Potentials, page-503

  1. 1,182 Posts.
    lightbulb Created with Sketch. 3879
    That is correct. Whilst Slukvin’s holding is in his personal name still, Vodyanik has moved his holding into a Nominees account a few years ago if I recall correctly.

    @ralom the important part here is when talking about the Cymerus process - it is covered via multiple patents, covering multiple different aspects. Whilst some are due to expire sooner, other patents still have a much longer lifetime.
    I believe to have covered the above in one of my previous posts already:
    https://hotcopper.com.au/threads/intellectual-property.4095934/?post_id=31968934

    I would have thought that you had done this sort of research prior to making your initial investment already. Same with the sub-sub-licensing issue I have mentioned before and as a result of that had been discussed on here extensively. Nonetheless I appreciate your questions on here as your questions may also be of interest to new holders. However, sometimes it might be viable to also DYOR.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $44.01M
Open High Low Value Volume
25.5¢ 25.5¢ 24.5¢ $23.65K 94.55K

Buyers (Bids)

No. Vol. Price($)
1 40000 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 36715 1
View Market Depth
Last trade - 15.10pm 29/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.